Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.

Nivolumab treatment seems safe and clinical efficacious. Patients with advanced liver disease require further prospective evaluation due to probable limited efficacy of nivolumab.